In the fourth quarter of 2024, we expect to announce updated data from the VTP-300 program in ongoing clinical trials in chronic hepatitis B at AASLD – The Liver Meeting® 2024 scheduled from November ...

Celiac disease is a digestive and immune disorder that can keep the body from absorbing necessary nutrients. "Our conception and awareness of celiac disease has evolved over the past few decades, but ...

In 2025, children within the TEDDY study will submit their final samples at research clinics in Sweden, Finland, Germany and ...

In 2025, children within the TEDDY study will submit their final samples at research clinics in Sweden, Finland, Germany and the United States. The international study has provided a lot of new ...

If you feel sick or uncomfortable after eating foods like bread or pasta, you're not alone. Millions of people struggle with ...

According to a study by the University of the Basque Country (UPV/EHU), the Internet is the go-to source for most people with celiac disease when tackling their dietary queries.

Females are five to eight times more likely to have thyroid disease than males. This includes hyperthyroidism (an overactive ...

But the reality of city living, indulging in colour treatments and too much heat styling, can take a toll on hair health. This is exactly why a bond repair hair treatment deserves a spot in your ...

The two leading treatment options are medication and surgery ... Colectomy (removing part or the entire colon) may be used in children with ulcerative colitis who experienced growth retardation. In ...

Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help people ...

Young adults with colon cancer are typically diagnosed at a later stage and with a more aggressive type of the disease, a new study says. Obesity, family history, inflammatory bowel disease ...

VYALEV (foscarbidopa and foslevodopa) is a solution of carbidopa and levodopa prodrugs for 24-hour continuous subcutaneous infusion for the treatment of motor fluctuations in adults with advanced PD.